Kimelman & Baird, LLC
- SEC CIK
- 0001318103
- Latest filing
- Aug 18, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Kimelman & Baird, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 27,671
- Value
- $17.3M
- % of portfolio
- 1.3%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 27,671 | $17.3M | 1.3% | +16,815+154.9% | Added | Holders |
| Q1 2026 | 10,856 | $8.39M | 0.7% | +10,542+3,357.3% | Added | Holders |
| Q4 2025 | 314 | $242.4K | <0.1% | +260+481.5% | Added | Holders |
| Q3 2025 | 54 | $30.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 54 | $28.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 54 | $34.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 54 | $38.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 54 | $56.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 54 | $56.8K | <0.1% | – | No prior filing | Holders |